secwatch.observer — SEC 8-K summary
======================================

Issuer:     Genprex, Inc. (GNPX)
CIK:        0001595248
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001437749-23-025064
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genprex receives Nasdaq deficiency notice for bid price below $1.00; 180 days to cure
--------------------------------------------------------------------------------

- Received Nasdaq letter on Aug 30, 2023 for failing Minimum Bid Price Requirement (bid <$1.00 for 30 consecutive trading days).
- Granted 180 calendar days until Feb 26, 2024 to regain compliance by having bid >=$1.00 for 10 consecutive business days.
- If not cured by Feb 26, may be eligible for extra 180-day period if meeting other listing standards and intends reverse split.
- No immediate effect on listing; trading continues on Nasdaq Capital Market.
- Company monitoring and assessing actions; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595248/000143774923025064/0001437749-23-025064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595248/000143774923025064/gnpx20230829c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-025064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer